(Q34713651)

4 August 2017

1 reference

title

Current problems and needs in the treatment of pT1 G3 bladder carcinoma (English)

1 reference

4 August 2017

author name string

Francisco Jose Martínez Portillo

series ordinal

1

1 reference

4 August 2017

Peter Alken

series ordinal

2

1 reference

4 August 2017

publication date

1 January 2002

1 reference

International Urology and Nephrology

4 August 2017

published in

1 reference

4 August 2017

volume

33

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

29-40

1 reference

Natural history of superficial bladder cancer. Prognostic features and long-term disease course

4 August 2017

cites work

1 reference

12 December 2020

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression

1 reference

12 December 2020

Uncertainty and outcome of invasive bladder tumors

1 reference

12 December 2020

Cystectomy for superficial bladder cancer

1 reference

12 December 2020

Local recurrence and survival following nerve-sparing radical cystoprostatectomy

1 reference

12 December 2020

[Therapy of superficial bladder carcinoma]

1 reference

12 December 2020

Bladder wall penetration of intravesical mitomycin C in dogs

1 reference

12 December 2020

Multivariate analysis of the prognostic factors of primary superficial bladder cancer

1 reference

12 December 2020

Effects of local bacillus Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall

1 reference

12 December 2020

Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients.

1 reference

12 December 2020

Can p53 help select patients with invasive bladder cancer for bladder preservation?

1 reference

12 December 2020

Predicting cancer progression in patients with stage T1 bladder carcinoma

1 reference

12 December 2020

Intravesical instillation of epirubicin hydrochloride in superficial bladder tumor--prophylactic and therapeutic instillation for carcinoma in situ

1 reference

12 December 2020

Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder

1 reference

12 December 2020

The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years

1 reference

12 December 2020

Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial

1 reference

12 December 2020

Office evaluation and management of bladder neoplasms

1 reference

12 December 2020

p53 immunoreactivity in biopsy specimens of T1G3 transitional cell carcinoma of the bladder--a helpful parameter in guiding the decision for or against cystectomy?

1 reference

12 December 2020

The management of invasive transitional cell carcinoma of the bladder. Results of definitive and preoperative radiation therapy in 390 patients treated at the Prince of Wales Hospital, Sydney, Australia

1 reference

12 December 2020

The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial. Members of the Dutch South East Cooperative Urological Group.

1 reference

12 December 2020

Is microstaging of early invasive cancer of the urinary bladder possible or useful?

1 reference

12 December 2020

Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome

1 reference

12 December 2020

T1 GIII bladder cancer. Management with transurethral resection only

1 reference

12 December 2020

The evaluation and follow-up of patients with Ta, Tcis, and T1 bladder cancer

1 reference

12 December 2020

The value of a second transurethral resection in evaluating patients with bladder tumors

1 reference

12 December 2020

Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy

1 reference

12 December 2020

Transurethral resection and sequential chemo-immunoprophylaxis in primary T1G3 bladder cancer

1 reference

12 December 2020

Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer

1 reference

12 December 2020

Progression of T1 bladder tumors: better staging or better biology?

1 reference

12 December 2020

Extravesical tumor relapse in patients with superficial bladder tumors

1 reference

12 December 2020

Intravesical bacille Calmette-Guérin in Stage T1 grade 3 bladder cancer therapy: a 7-year follow-up.

1 reference

12 December 2020

Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor?

1 reference

12 December 2020

Radical cystectomy for historical and pathologic T1, N0, M0 (stage A) transitional cell cancer. Need for adjuvant systemic chemotherapy?

1 reference

12 December 2020

A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder

1 reference

12 December 2020

A critical analysis of the use of p53 as a marker for management of bladder cancer

1 reference

12 December 2020

The treated natural history of high risk superficial bladder cancer: 15-year outcome

1 reference

12 December 2020

Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: A new proposal.

1 reference

12 December 2020

A randomized study of intravesical mitomycin C, bacillus Calmette-Guerin Tice and bacillus Calmette-Guerin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder

1 reference

12 December 2020

The natural history of a T1 bladder cancer: life-long tumour diathesis

1 reference

12 December 2020

Stage T1 bladder cancer: grade is the primary determinant for risk of muscle invasion

1 reference

12 December 2020

The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2)

1 reference

12 December 2020

Ta and T1 bladder cancer: location, recurrence and progression

1 reference

12 December 2020

The pT1 G3 bladder tumour

1 reference

12 December 2020

Late invasive recurrence despite long-term surveillance for superficial bladder cancer.

1 reference

12 December 2020

1 reference

12 December 2020

Is transurethral biopsy of the bladder necessary after 3 months to evaluate response to bacillus Calmette-Guerin therapy?

1 reference

12 December 2020

1 reference

12 December 2020

Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS). The American Urological Association

1 reference

12 December 2020

Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification

1 reference

12 December 2020

Early cystectomy for clinical stage T1 transitional cell carcinoma of the bladder

1 reference

12 December 2020

When intravesical measures fail. Indications for cystectomy in superficial disease

1 reference

12 December 2020

Infiltrating carcinoma of the bladder; relation of depth of penetration of the bladder wall to incidence of local extension and metastases

1 reference

12 December 2020

Contemporary results of radical radiotherapy for bladder transitional cell carcinoma in a district general hospital with cancer-centre status.

1 reference

12 December 2020

Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction

1 reference

12 December 2020

Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder.

1 reference

12 December 2020

Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.

1 reference

12 December 2020

Radiation therapy in regionally advanced bladder cancer

1 reference

12 December 2020

Dissecting the immunobiological effects of Bacillus Calmette-Guérin (BCG) in vitro: evidence of a distinct BCG-activated killer (BAK) cell phenomenon

1 reference

12 December 2020

Progression of T1 bladder tumors: better staging or better biology?: reply

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1014492517088

1 reference

4 August 2017

1 reference